Mitochondrial Changes in Cidofovir Therapy for BK Virus Nephropathy

Transplantation Proceedings

Volumn 42, Issue 5, 2010, Pages 1713-1715

  Talmon, G ^a   Cornell, L D ^a   Lager, D J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ADULT; AGED; ARTICLE; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MITOCHONDRIAL TOXICITY; MITOCHONDRION SWELLING; POLYOMAVIRUS INFECTION; POLYOMAVIRUS NEPHROPATHY; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTIVIRAL AGENTS; BIOPSY; BK VIRUS; CYTOSINE; HUMANS; KIDNEY TUBULES, PROXIMAL; MIDDLE AGED; MITOCHONDRIA; PHOSPHONIC ACIDS; POLYOMAVIRUS INFECTIONS;

EID: 77953661284     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.11.039     Document Type: Article

References (4)

1. Tanji N., Tanji K., Kambham N., et al. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32 (2001) 734
2. Daugas E., Rougier J.P., and Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int 67 (2005) 393
3. Kakuda T.N. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22 (2000) 685
4. Safrin S. Antiviral agents. In: Katzung B.G. (Ed). Lange pharmacology (2007). http://www.accessmedicine.com/content.aspx?aID=2510455 Accessed March 31, 2008